Pfizer RSV vaccine 82% effective vs severe infection in infants, final data showed
On Apr. 5, 2023, Pfizer announced that experimental respiratory syncytial virus (RSV) vaccine was 82% effective in preventing…
On Apr. 5, 2023, Pfizer announced that experimental respiratory syncytial virus (RSV) vaccine was 82% effective in preventing…
On Apr. 4, 2023, NanoViricides announced that it had executed a license agreement with Karveer Meditech, Kolhapur, India,…
On Mar. 24. 2023, antibiotics do not reduce the risk of dying in adults hospitalized with COVID-19, the…
On Mar. 23. 2023, researchers at Washington University School of Medicine in St. Louis and the Veterans Affairs…
On Mar. 21, 2023, Quest Diagnostics announced that it had introduced two innovative Post-COVID-19 panels. These laboratory tests…
On Mar. 21, 2023, the Ministry of Health of the United Republic of Tanzania declared an outbreak of…
On Mar. 17, 2023, the Indonesia Ministry of Health notified WHO of the detection of a circulating vaccine-derived…
On Mar. 15, 2023, scientists at Texas A&M announced that a research study: モRNA interference is essential to…
On Mar. 15, 2023, the UK Animal and Plant Health Agency reported that the carcesses of Common dolphins…
On Feb. 28, 2023, a team from the University of Sydney reported that a flu virus found in…
On Feb. 26, 2023, the Cambodia International Health Regulations (IHR) National Focal Point (NFP) reported one confirmed case…
On Feb. 24, 2023, the U.S. Food and Drug Administration issued an emergency use authorization (EUA) for the…
On Feb. 22, 2023, the Centers for Disease Control and Prevention (CDC) reported that the 2022-2023 flu vaccines…
On Feb. 15, 2023, it was reported that a 53-year-old man in Germany had become at least the…
On Feb. 14, 2023, scientists from the National Institute of Allergy and Infectious Diseases announced they had developed…
On Feb. 13, 2023, Equatorial Guinea today confirmed its first-ever outbreak of Marburg virus disease. Preliminary tests carried…
On Feb. 8, 2023, as bird flu continues to circle the globe, a new report suggested that the…
On Feb. 8, 2023, BD announced that it had received Emergency Use Authorization from the U.S. Food and…
On Feb. 7, 2023, the U.S. Department of Agricultureï¾’s Research Service announced that it was implementing a $300…
On Feb. 2, 2023, a National Institutes of Health research group with extensive experience studying ebolavirus countermeasures successfully…
On Jan. 17, 2023, Moderna announced positive topline data from its ConquerRSV Phase 3 pivotal efficacy trial of…
On Jan. 17, 2023, the Montana Fish and Wildlife Commission reported that juvenile grizzly bears tested positive for…
On Jan. 11, 2023, Uganda declared the end of the Ebola disease outbreak caused by Sudan ebolavirus, less…
On Jan. 11, 2023, Roche announced treatment of uncomplicated influenza and for post-exposure prophylaxis of influenza. Post-exposure prophylaxis…
On Jan. 11, 2023, the U.S. Food and Drug Administration reported that a single booster dose with an…
On Jan. 10, 2023, the WHO announced that an estimated 5 million children died beforecoronavirus_omicron_illustrationeir fifth birthday and…
On Jan. 10, 2023, the National Institutes of Health reported that antiviral treatments can help reduce the risk…
On Jan. 9, 2023, BD (Becton, Dickinson) and CerTest Biotec have announced Emergency Use Authorization (EUA) from the…
On Jan. 4, 2023, a National Institutes of Health funded study reported that moderate levels of two outdoor…
On Dec. 20, 2022, the University of Oxford announced study results using data from 7 million people notified…